NFKB1 and cancer: Furthermore, deficiency in nitric oxide synthesis and ROS production may also interfere with downregulation of NF-κB and its downstream mediators (43), further exacerbating the inflammatory responses, similarly reported in the development of diabetes, neuropathy, and cancer (44).